Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Background: The emergence of antifungal resistance threatens effective treatment of invasive fungal infection (IFI). Invasive candidiasis is the most common health care–associated IFI. We evaluated the activity of fluconazole (FLU) against 20 788 invasive isolates of Candida (37 species) collected from 135 medical centers in 39 countries (1997–2016). The activity of anidulafungin, caspofungin, and micafungin (MCF) was evaluated against 15 308 isolates worldwide (2006–2016). Methods: Species identification was accomplished using phenotypic (1997–2001), genotypic, and proteomic methods (2006–2016). All isolates were tested using reference methods and clinical breakpoints published in the Clinical and Laboratory Standards Institute documents. Results: A decrease in the isolation of Candida albicans and an increase in the isolation of Candida glabrata and Candida parapsilosis were observed over time. Candida glabrata was the most common non–C. albicans species detected in all geographic regions except for Latin America, where C. parapsilosis and Candida tropicalis were more common. Six Candida auris isolates were detected: 1 each in 2009, 2013, 2014, and 2015 and 2 in 2016; all were from nosocomial bloodstream infections and were FLU-resistant (R). The highest rates of FLU-R isolates were seen in C. glabrata from North America (NA; 10.6%) and in C. tropicalis from the Asia-Pacific region (9.2%). A steady increase in isolation of C. glabrata and resistance to FLU was detected over 20 years in the United States. Echinocandin-R (EC-R) ranged from 3.5% for C. glabrata to 0.1% for C. albicans and C. parapsilosis. Resistance to MCF was highest among C. glabrata (2.8%) and C. tropicalis (1.3%) from NA. Mutations on FKS hot spot (HS) regions were detected among 70 EC-R isolates (51/70 were C. glabrata). Most isolates harboring FKS HS mutations were resistant to 2 or more ECs. Conclusions: EC-R and FLU-R remain uncommon among contemporary Candida isolates; however, a slow and steady emergence of resistance to both antifungal classes was observed in C. glabrata and C. tropicalis isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Historically this organism has been pan-susceptible to triazoles, echinocandins, and amphotericin B.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although relatively low levels of resistance for most Candida species have been described, the outcomes for candidemia remain poor, as high levels of mortality (15%-50%) have been associated with candida infections7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this Review, we explore the molecular mechanisms that contribute to antifungal drug resistance, with a focus on Candida spp., the most common cause of fungal infections in humans7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“Sentinel surveillance programs designed to capture organisms and patient demographic data from representative sites spanning a larger geographical area and over a longer period of time serve to fill the gaps in time and space that are necessarily left by the more intensive and focused, yet intermittent, population-bas…”
BackgroundSelf-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953 · cited 1×
“The burden of invasive fungal infections (IFIs) for patients and health care systems is difficult to measure [2, 12]; however, it is well recognized that IFIs are associated with high morbidity and mortality rates and elevated health care costs.”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 2×
“S90 • OFID 2019:6 (Suppl 1) • Pfaller et al SENTRY Program Candida Surveillance (1997–2016) • OFID 2019:6 (Suppl 1) • S91 [93, 94], and emerging resistance mechanisms [20, 68] highlight the importance of local and global surveillance studies.”
BackgroundSelf-citationKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · cited 1×
“Caspofungin, micafungin, and anidulafungin were approved for clinical use by the US Food and Drug Administration (FDA) in 2001, 2005, and 2006, respectively, and are now recommended as firstline agents for treating IC [50, 67].”
BackgroundCalderone, R. (2012) · ASM Press eBooks · Cited by 912
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Self-citation
Research works printed but not linked: 4
- 38. CLSI. M27-S4. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: 4th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
- 39. CLSI. M27-A3. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- 40. CLSI. M59. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. 1st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
- 63. Pfaller MA, Diekema DJ Azole antifungal drug cross-resistance: mechanisms epidemiology, and clinical significance. J Invasive Fungal Infect 2007; 1: 74– 92.
Cited by
Items 601–700 of 931
Esposito, A., Migliaccio, A., Iula, V. D., Zarrilli, R., Guaragna, A., & Gregorio, E. D. (2021) · Antibiotics · doi:10.3390/antibiotics10111396 · Cited by 3
The changing landscape of azole-resistant invasive candidiasis
Ben‐Ami, R. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.04.023 · Cited by 3
Wang, Y., Wan, X., Zhao, L., Jin, P., Zhang, J., Zhou, X., Ye, N., Wang, X., Pan, Y., & Xu, L. (2023) · Medical Mycology · doi:10.1093/mmy/myad097 · Cited by 3
Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi
Takahashi, J. A., Marques, J. G. S., Ferreira, M. R., dos Santos, T. P., & Rosário, G. O. C. (2024) · Springer eBooks · doi:10.1007/978-981-99-5696-8_1 · Cited by 3
Bacterial, Viral, Fungal and Parasitic Coinfections
Özdemir, Ö., & Yılmaz, E. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.114738 · Cited by 3
Won, E. J., Sung, H., & Kim, M. (2024) · Journal of Fungi · doi:10.3390/jof10090624 · Cited by 3
Abe, M., Sekizuka, T., & Miyazaki, Y. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102658 · Cited by 3
Epidemiology of Invasive Fungal Infections
Karakoç, Z. Ç. (2020) · Klimik Dergisi/Klimik Journal · doi:10.5152/kd.2019.53 · Cited by 3
Wong, H. M., Sim, J. H. C., Zhou, Y. P., & Chien, J. M. F. (2020) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000813 · Cited by 3
Acosta, S., Moreno-Aguilar, C., Hernández-Sánchez, D., Morales‐Cruzado, B., Sarmiento‐Gómez, E., Bittencourt, C., Sánchez-Vargas, L. O., & Quintana, M. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.90 · Cited by 3
Invasive para-aortic Candida glabrata: a multidisciplinary management challenge
Miller, R., Harris, S., Porter, R., & Burnett, H. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-240710 · Cited by 3
Pancholi, V. (2021) · International Archives of Medical Microbiology · doi:10.23937/2643-4008/1710014 · Cited by 3
A previously unreported case of suppurative thrombophlebitis due to Clavispora lusitaniae
Yoneda, T., Hoshina, T., Fukuda, T., Ohama, N., Murakawa, S., & Kusuhara, K. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101390 · Cited by 3
Nakaseomyces glabrata endocarditis: A therapeutic dilemma
Jim, K. K., Daems, J. J. N., Boekholdt, S. M., & van Dijk, K. (2023) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2023.04.002 · Cited by 3
Antifungal Properties of Ethanolic Extract of Holarrhena Pubescens against Candida Species
Bhowmick, T., Chaudhuri, B. N., Guchhait, P., & Das, S. (2023) · South Asian Research Journal of Biology and Applied Biosciences · doi:10.36346/sarjbab.2023.v05i04.002 · Cited by 3
Rashidi, M., Bazı, A., Ahmadzadeh, A., Romeo, O., Rezaei‐Matehkolaei, A., Abastabar, M., Haghani, I., & Mirzaei, S. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad201 · Cited by 3
Bozkurt, N. B., & Kalkancı, A. (2021) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.920675 · Cited by 3
Karkowska‐Kuleta, J., & Maddi, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1064386 · Cited by 3
How can we optimize antifungal use and stewardship in the treatment of acute leukemia?
Taynton, T., Allsup, D. J., & Barlow, G. D. (2024) · Expert Review of Hematology · doi:10.1080/17474086.2024.2383401 · Cited by 2
TECHNICAL AND PATENT PERSPECTIVE ON FILM FORMING TOPICAL SPRAYS
Dehghan, M. H., & Rajput, S. K. (2024) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2024v16i12.52109 · Cited by 2
Hoseinnejad, A., Mahdizade, A. H., Erfaninejad, M., Kermani, F., Ghazanfari, M., Arbabi, A., Bahreiny, S. S., Bozorgomid, A., Moradi, M., Haghani, I., et al. (2024) · PubMed Central · doi:10.22034/cmm.2024.345248.1595 · Cited by 2
Fungal DNA‐barcoding on a chip: Magnetoresistive biosensors for yeast infection diagnosis
Zolotareva, M., Cascalheira, F., Afonso, R., Corado, M., Martins, A., Caneiras, C. S. G., Bárbara, C., Teixeira, M. C., & Caetano, D. M. (2025) · View · doi:10.1002/viw.20250015 · Cited by 2
Anaele, E. N., Okafor, J. I., re, L. A. F., Passo, C. L., Mediati, F., Galeano, G., Romeo, O., Galbo, R., & Giuffrè, L. (2025) · International Journal of Microbiology · doi:10.1155/ijm/3115363 · Cited by 2
Mustafa, S., Chaudhry, M., Tariq, T. M., Tufail, Z., Manzoor, F., & Shahzad, R. (2025) · JAIMC Journal of Allama Iqbal Medical College · doi:10.59058/dcrqd453 · Cited by 2
Parnandi, V. A., Trivedi, P. M., Panchal, H., Suryawanshi, G., & Patkar, R. (2025) · Current Biology · doi:10.1016/j.cub.2025.10.082 · Cited by 2
Paul, R., Agarwal, S. G., Goenka, A., Jain, S., Singh, K., Raghuwanshi, V. S., Agarwal, A., Singh, K. G., Rodrigues, S., & Sen, V. (2025) · Indian Journal of Microbiology Research · doi:10.18231/j.ijmr.12137.1763613786 · Cited by 2
Kim, T. Y., Byun, J., Liu, C., Yang, D., Lee, H.-S., Sung, H., Kim, M. G., & Won, E. J. (2025) · Annals of Laboratory Medicine · doi:10.3343/alm.2025.0320 · Cited by 2
Horishny, V. Y., Mural, D., Kovalenko, I., Finiuk, N. S., Ivasechko, I., Konechnyi, Y., Tymchuk, I. V., Nedzelskyi, S., Kozak, Y., Rumynska, T. M., et al. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118545 · Cited by 2
Maqueda-Cabrera, E. E., & Cuéllar‐Cruz, M. (2026) · Current Microbiology · doi:10.1007/s00284-025-04715-y · Cited by 2
Zhou, X., Hilk, A. L., Solis, N. V., Scott, N. E., Zajac, C., Filler, S. G., & Selmecki, A. M. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003631 · Cited by 2
Candida glabrata and the host: a neglected affair
Ghosh, M., Raney, M., & Kaur, R. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002161 · Cited by 2
Lipid-Based Drug Delivery Systems as Emerging Tools to Overcome Antifungal Resistance
Arana, L., Guridi, A., Sevillano, E., Tamayo, E. H., Eraso, E., Alkorta, I., & Maté, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104487 · Cited by 2
Marcano, D., Eremin, S., Ramón-Pardo, P., Forastiero, A., Galas, M., da Matta, D. A., Nóbrega, D. B., Dobreva, Z., Chayakulkeeree, M., Shin, J. H., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104019 · Cited by 2
Carolis, E. D., Cosio, T., Magrì, C., Mondo, M. D., Torelli, R., Liotti, F. M., Bernaschi, P., Inzeo, T. D., Vento, G., & Sanguinetti, M. (2026) · Pathogens · doi:10.3390/pathogens15070724 · Cited by 2
Papadimitriou‐Olivgeris, M., Spiliopoulou, A., Fligou, F., Tsiata, E., Kolonitsiou, F., Nikolopoulou, A., Papamichail, C., Spiliopoulou, I. T., Marangos, M. N., & Christofidou, M. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001401 · Cited by 2
In-vitro and In-vivo Anti-Candidal Effect of Cnidoscolus aconitifolius Leaves Extracts
Adindu, J. C., Anyamene, C. O., Ezebialu, C. U., Chukwukaelo, D. C., Chude, C. F., Eruala, L. E., & Umeofor, A. (2023) · Journal of Advances in Microbiology · doi:10.9734/jamb/2023/v23i6729 · Cited by 2
Chen, Y.-C., Ho, M., Chao, W., & Chang, C. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823000894 · Cited by 2
AL-DARRAJI, Z. D. G., & Mohammed-Ameen, M. K. (2023) · Biodiversitas Journal of Biological Diversity · doi:10.13057/biodiv/d240761 · Cited by 2
Li, P., Li, Y., Zhang, Y., Zhu, S., Pei, Y., Zhang, Q., Liu, J., Bao, J., & Sun, M. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1281759 · Cited by 2
Sabadin, C. E. S., da Matta, D. A., Hoppe, L., Fernandes, F. A. V., Melo, A. S. D. A., Rigo, L., & Barbosa, D. A. (2024) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2024ao0138 · Cited by 2
Status and Challenge of Antifungal Stewardship at the Osaka Metropolitan University Hospital
YAMADA, K., & Kakeya, H. (2024) · Medical Mycology Journal · doi:10.3314/mmj.24.003 · Cited by 2
Rozaliyani, A., Nelwan, E. J., Wahid, M. H., Aditianingsih, D., Karyanti, M. R., Pratiekauri, S., Susilo, A., Isbaniyah, F., Agustin, H., Saharman, Y. R., et al. (2024) · Acta medica Indonesiana · Cited by 2
Trevijano‐Contador, N., López‐Peralta, E., López‐López, J., Roldán, A., de Armentia, C., & Zaragoza, Ó. (2024) · Mycoses · doi:10.1111/myc.13811 · Cited by 2
Molecular characterization of non-Cryptococcus yeast communities isolated from Eucalyptus trees.
Nouraei, H., Gharechahi, F., Zareshahrabadi, Z., Zomorodian, K., Gharavi, A., Khodadadi, H., Ansari, S., Amirzadeh, N., & Pakshir, K. (2024) · PubMed Central · doi:10.22034/cmm.2024.345184.1500 · Cited by 2
Kawasaki, K., Sawai, T., Inadomi, Y., Morimitsu, S., Ikeda, T., Yoshioka, S., Matsuo, N., Kadota, J., Yanagihara, K., & Mukae, H. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102662 · Cited by 2
ANTIFUNGAL ACTIVITY OF A PHOSPHORYLATED 3-(α-HYDROXYALKYL) ALLENES ETHANOL EXTRACTS
Ibryamova, S. F., Hasanov, H. H., & Ignatova-Ivanova, T. V. (2020) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2020263.3328 · Cited by 2
Sabadin, C. E. S., Lima, S. L., Gompertz, O. F., Santana, G. N. P., Melo, A. S. D. A., Rigo, L., da Matta, D. A., & Barbosa, D. A. (2020) · Medical Mycology · doi:10.1093/mmy/myaa085 · Cited by 2
Regional spread of Candida auris
Barantsevich, N. E., Levanova, V. V., & Barantsevich, E. P. (2021) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2021.2.117-125 · Cited by 2
Lung nodules due to Candida parapsilosis in a person with cystic fibrosis
Piechowiak, M. B., Brown, A. W., Aryal, S., & Katugaha, S. B. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-245441 · Cited by 2
Zap1 is required for Candida glabrata response to fluconazole
Gaspar‐Cordeiro, A., Afonso, G. S., Amaral, C., da Silva, S. M., & Pimentel, C. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foab068 · Cited by 2
Candida Infections in Solid Organ Transplantation
Barros, N., & Mansour, M. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_43-1 · Cited by 2
Raj, K., Rishi, P., Shukla, G., Rudramurhty, S. M., Mongad, D., & Kaur, A. (2022) · Indian Journal of Microbiology · doi:10.1007/s12088-022-01036-7 · Cited by 2
Conditional Protein Depletion in the Analysis of Antifungal Drug Resistance in Candida glabrata
Conway, T. P., & Moye-Rowley, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3155-3_13 · Cited by 2
Amen, A., Ahmed, E. H., Elgendy, S., Bayoumi, S. A. L., Hameed, M. R. A., & Abd-Alrahman, E. (2023) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2023.207806.1735 · Cited by 2
Lima, T. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/5mtr-v706 · Cited by 2
Pfaller, M. A., Carvalhaes, C. G., Rhomberg, P. R., Messer, S. A., & Castanheira, M. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00460-z · Cited by 2
Self-citationChemoproteomic Profiling of C. albicans for Characterization of Anti-fungal Kinase InhibitorsPreprint
Shirley, D. J., Nandakumar, M., Cabrera, A., Yiu, B., Puumala, E., Liu, Z., Robbins, N., Whitesell, L. J., Smith, J. L., Lyons, S. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.10.632200 · Cited by 2
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0134 · Cited by 2
Portela, F. V. M. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Montoya, M. C., & Krysan, D. J. (2020) · UR Research (University of Rochester) · Cited by 2
Kluyveromyces marxianus (Candida kefyr)
Noguera, M. (2022) · Boletín micológico · doi:10.22370/bolmicol.2022.37.1.3225 · Cited by 1
In vitro antifungal activity and phytochemical analysis of lichen Parmelia perlata (L.) Ach.
Singh, V., & Singh, D. (2020) · International Journal of Pharmacognosy and Life Science · doi:10.33545/27072827.2020.v1.i1a.51 · Cited by 1
Zaki, A., Gonzales-Luna, A. J., Beyda, N. D., Lasco, T. M., & Garey, K. W. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2804 · Cited by 1
Predictors of outcomes in patients with candidemia in an Intensive Care Unit
Özel, A. S., Altunal, L. N., Şengel, B. E., Aslan, M., & Aydın, M. (2023) · Marmara medical journal · doi:10.5472/marumj.1367454 · Cited by 1
Infections fongiques en réanimation
Soulier-Zaninka, Q., Lefebvre, T., Bayart, G., Viart, C., Tarpin, P., & Dupont, H. (2024) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.11.003 · Cited by 1
Diallo, S. N., Yerbanga, I. W., Bado, B., Mandy, I., Anantharajah, A., Montesinos, I., Denis, O., Bamba, S., & Rodriguez‐Villalobos, H. (2024) · African Journal of Parasitology Mycology and Entomology · doi:10.35995/ajpme2010001 · Cited by 1
Evaluation of Candidemia Cases Developed in the Intensive Care Unit: A Ten-Year Analysis
UĞUR, Ö., BALASAR, B., Demirel, S., Demirel, H. F., Tomruk, M., & EROĞLU, E. (2024) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1254373 · Cited by 1
Pasley, T., Baladad, C. B., DeSear, K., Karimi, S., Rubido, E., Helou, G. E., & Converse, M. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae525 · Cited by 1
Kountchou, C. L., Kabtani, J., Dougue, A. N., Nangwat, C., Ekpo, A. I., Essome, M. C. N., Mogo, C. B., Dzoyem, J. P., Ranque, S., & Ngouana, T. K. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01569-7 · Cited by 1
Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis
Korem, M., Reich, S., Rahav, G., Yahav, D., Weinberger, M., Novikov, A., Mizrahi, N., & Ben‐Ami, R. (2025) · Mycoses · doi:10.1111/myc.70017 · Cited by 2
Hunutlu, F. Ç., Özkalemkaş, F., Ener, B., Demirayak, D., Çalışır, B., Öztop, H., Pınar, İ. E., Gürsoy, V., Ersal, T., Koca, T. G., et al. (2025) · Journal of Fungi · doi:10.3390/jof11090630 · Cited by 1
Lovo, C. B., Ramos, I. V. G., Silva, L. D., Lopes, N. C., Durlacher, R. R., Rodrigues, R. S., Kuehn, C. C., Souza, E. B., Carvalho, C. M., & Matos, N. B. (2025) · Brazilian Journal of Biology · doi:10.1590/1519-6984.291553 · Cited by 1
Borges, J. C. E., Siqueira, L. P. M., de Freitas, V. L. T., de Oliveira, V. F., Magri, A. S. G. K., da Silva, A. R., de Araújo, E. D. M. P. A., Cury, A. P., & Magri, M. M. C. (2025) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202567064 · Cited by 1
Li, W., Zhang, Y., Zhuang, X., Ma, Z., Sui, Y., & Yang, L. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108104 · Cited by 1
Watcharasuwanseree, J., Chueansuwan, W., Suwantarat, N., Santimaleeworagun, W., Juntanawiwat, P., Sangchankoom, A., & Saelim, W. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s549066 · Cited by 1
Echinocandin-resistant Candida albicans: A case report from Japan
Hikida, S., Akiyama, Y., Ishikane, M., Shimazu, H., Nasu, R., Shinohara, T., Nagi, M., Shirai, R., Onakado, M., Nakayama, N., et al. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102856 · Cited by 1
Wang, Z., Xiong, L., Ma, K., Liu, J., Feng, K., & Peng, Y. (2025) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2025.101597 · Cited by 1
Pawar, K., & Singh, A. K. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002083 · Cited by 1
Cytrynbaum, E. G., & McClean, M. N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115740 · Cited by 1
Current scenario of antifungal resistance and the drugs in the pipeline
Sengar, D., Burade, D. K., Chaudhari, B. P., & Gajbhiye, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29273-6.00014-x · Cited by 1
Misawa, S., Chonan, M., Sano, M., Igawa, G., Takahashi, M., Ito, K., Nagasawa, T., Furusawa, K., Otsuka, S., Takeda, S., et al. (2025) · Medical Mycology Journal · doi:10.3314/mmj.25-00005 · Cited by 1
Zhao, M., Niimi, M., Cannon, R. D., & Lamping, E. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1721050 · Cited by 1
Sachdeva, C., Acharya, S. P., Sairam, A., & Murali, T. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-31858-6 · Cited by 1
Epidemiology and Management of Antifungal-Resistant Bloodstream Infections in Healthcare Settings
Sayyouh, O. (2025) · Infectious diseases · doi:10.5772/intechopen.1012710 · Cited by 1
Sun, J., Liang, X., Chen, Y., Guo, Y. C., Xu, Y., & Kang, H. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s583024 · Cited by 1
Lysková, P., Dobiáš, R., Bezdíček, M., Hubka, V., Sumerauerová, P., Lžičařová, D., Kocmanová, I., Buchta, V., Prošková, I., Janouškovcová, H., et al. (2026) · Mycopathologia · doi:10.1007/s11046-026-01076-3 · Cited by 1
Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance
Gatadi, S., Kumar, N. P., Sridevi, B., Borra, P. B., Thapar, P., & Wani, A. (2026) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2026.16158 · Cited by 1
Gu, M., Zhu, C. L., Xia, W., Ni, F., Jin, F., Huang, Y.-J., & Wang, J. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s613320 · Cited by 1
Zhao, Y., Dai, R., Liu, F., Liu, K. Q., Kang, W., Zhang, G., Li, J., Zhang, J., Wang, T., Gao, H., et al. (2026) · Emerging Microbes & Infections · doi:10.1080/22221751.2026.2695535 · Cited by 1
Gürcüoğlu, E., Çalışkan, G., Benli, M. T., & Timur, D. (2026) · Journal of Fungi · doi:10.3390/jof12080563 · Cited by 1
Uddin, Z., Tahsin, S., Valíčková, K., Long, T., Macedo, L. F. D., Popencuk, G., Zhao, Y., & Healey, K. R. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03874-25 · Cited by 1
Lin, S., Huang, Y., Huang, H., Hung, W., Tseng, Y.-T., & Lu, P. (2026) · Mycoses · doi:10.1111/myc.70217 · Cited by 1
Molecular mechanisms, pathogenesis and therapeutic advances of Candida albicans in oral candidiasis
Sahu, B. K., Debta, P., Patra, S. K., Sahu, M. C., Mohanta, T. K., & Panda, S. K. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1918424 · Cited by 1
Anita G. Rathod, A. R. R., Raut, A. R., Jaiswal, S. R., Awaghate, P. D., P.Holey, P., Sayyed, S. A., Lasure, A. B., Karale, M. K., & Rasve, V. (2025) · Cuestiones de Fisioterapia · Cited by 1
A gene network regulating echinocandin heteroresistance in Candida glabrata
Harrington, A. A., & Cunningham, K. W. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00549-26 · Cited by 1
Some issues of the resistance of Candida glabrata to echinocandins
Veselov, A. V. (2019) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2019.4.324-329 · Cited by 1
Ide, S., Kinoshita, N., Nomoto, H., Nakamura, K., Ota, M., Mezaki, K., Nakamura, S., Miyazaki, Y., Kutsuna, S., Hayakawa, K., et al. (2021) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.95.141 · Cited by 1
Battu, A., Purushotham, R., & Kaur, R. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4210 · Cited by 1
Metadata
- Authors
- Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N.
- Affiliations
- University of Iowa (US)
- The University of Adelaide (AU)
- JMI Laboratories (US)
- Corresponding author
- Pfaller, Michael A
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03
- Volume
- 6
- Issue
- Supplement_1
- Pages
- S79-S94
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC6419901
- OpenAlex
- W2922388167
- Semantic Scholar
- b99f36f4463b9afe6d2a0ab52eebb3f5e726f4c0
- Cited by
- 825
- References
- 114
- Citations by year
- 2026: 92 · 2025: 129 · 2024: 133 · 2023: 141 · 2022: 94 · 2021: 108 · 2020: 104 · 2019: 24
- FWCI
- 63.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- JMI Laboratories
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- invasive candidiasis, Candida species, antifungal resistance, fluconazole resistance, echinocandin resistance, Candida glabrata, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida auris, micafungin resistance, caspofungin, anidulafungin, Candida species distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.